Back to all studies
RecruitingACTRN12622000990729

A controlled study assessing the effect of the electronic smoking cessation resource Screen2Quit on the self-reported and biochemically verified quit rate in smokers undergoing lung cancer screening

The registry lists this study as recruiting. Study locations are listed in Australia and in Canada. Confirm recruitment at each site. It focuses on nicotine addiction; Lung cancer screening.

Addiction, nicotine addiction, ...DeviceFrom 50 Years to No limit
In plain English

Key information made simple

What the source says

The registry describes this research topic: “Screen2Quit: An electronic smoking cessation resource for smokers undergoing lung cancer screening”. This is an interventional study. The registry lists a target sample size of 690. Recruitment status at the registry update of 2026-09-03: recruiting. Read the original description and eligibility criteria, and confirm the practical details with the study team.

What should you check before joining?

Check the full criteria in the official source. Ask the team to confirm recruitment, locations, visits, risks and participation requirements.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJuly 13, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
690
Sponsor
The University of Queensland
Sponsor type
University
Study type
Device
Intervention type
Treatment: Other, DEVICE
Study phase
Not ApplicableFormal phases are mostly used for medication studies and some device studies. Some studies do not use a phase.
Locations
Australia, Canada
Age range
From 50 Years to No limit
Official registry ID
ACTRN12622000990729
Official title
A randomised controlled trial assessing the effect of the electronic smoking cessation resource Screen2Quit on the self-reported and biochemically verified quit rate in smokers undergoing lung cancer screening

Want help reviewing this study?

Loading the security check...
Study ID: ACTRN12622000990729. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Australia · 6 sites
  • The Prince Charles Hospital
    Chermside
    Site status: Not listed — confirm with the team
  • St Vincent's Hospital (Darlinghurst)
    Darlinghurst
    Site status: Not listed — confirm with the team
  • Royal Melbourne Hospital - City campus
    Parkville
    Site status: Not listed — confirm with the team
  • Epworth Eastern Hospital
    Box Hill
    Site status: Not listed — confirm with the team
  • Sir Charles Gairdner Hospital
    Nedlands
    Site status: Not listed — confirm with the team
  • Fiona Stanley Hospital
    Murdoch
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring digital app or tool for people with addiction. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study. The listed phase is Not Applicable. Ask the study team what that means in practice for safety, monitoring, and criteria.

Are there criteria about substance use or wanting to reduce it?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Will I need to change, stop, or stabilize my current treatment?

The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by The University of Queensland, which appears to be a university. The listed contact or investigator is Peter Vardon. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me